PFA Pension Forsikringsaktieselskab acquired a new stake in shares of Cigna Group (NYSE:CI - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 189,982 shares of the health services provider's stock, valued at approximately $52,526,000. PFA Pension Forsikringsaktieselskab owned approximately 0.07% of Cigna Group as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Beacon Financial Strategies CORP acquired a new stake in Cigna Group during the fourth quarter valued at approximately $28,000. Collier Financial acquired a new stake in Cigna Group during the third quarter valued at approximately $34,000. Lodestone Wealth Management LLC acquired a new stake in Cigna Group during the fourth quarter valued at approximately $32,000. Activest Wealth Management raised its stake in Cigna Group by 1,050.0% during the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider's stock valued at $38,000 after buying an additional 126 shares in the last quarter. Finally, Founders Capital Management raised its stake in Cigna Group by 53.0% during the third quarter. Founders Capital Management now owns 153 shares of the health services provider's stock valued at $44,000 after buying an additional 53 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.
Insider Buying and Selling
In other Cigna Group news, insider Everett Neville sold 1,719 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares of the company's stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.60% of the company's stock.
Cigna Group News Roundup
Here are the key news stories impacting Cigna Group this week:
- Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
- Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an "outperform" rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
- Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
- Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
- Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
- Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
- Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.
Wall Street Analyst Weigh In
Several brokerages have issued reports on CI. Wall Street Zen upgraded Cigna Group from a "hold" rating to a "buy" rating in a research note on Saturday, February 7th. Deutsche Bank Aktiengesellschaft upped their target price on Cigna Group from $301.00 to $304.00 and gave the company a "buy" rating in a report on Tuesday, February 10th. Wells Fargo & Company increased their price objective on Cigna Group from $300.00 to $305.00 and gave the stock an "equal weight" rating in a report on Friday. Truist Financial increased their price objective on Cigna Group from $320.00 to $350.00 and gave the stock a "buy" rating in a report on Tuesday, February 17th. Finally, UBS Group reissued a "buy" rating and issued a $375.00 price objective on shares of Cigna Group in a report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $336.20.
View Our Latest Stock Report on Cigna Group
Cigna Group Stock Performance
CI opened at $283.14 on Friday. The company has a market capitalization of $74.62 billion, a price-to-earnings ratio of 12.00, a price-to-earnings-growth ratio of 0.98 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.74. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The business has a 50 day moving average price of $274.34 and a two-hundred day moving average price of $276.81.
Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts' consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm's revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts predict that Cigna Group will post 30.41 EPS for the current fiscal year.
Cigna Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group's dividend payout ratio is 28.13%.
About Cigna Group
(
Free Report)
Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.